A. V. Shubina

929 citations
4 papers · 669 indexed · 1 hit paper · h-index 3
Topics
HIV/AIDS drug development and treatment (2 papers)Multiple Myeloma Research and Treatments (2 papers)Peptidase Inhibition and Analysis (1 paper)
Journals
SHILAP Revista de lepidopterologíaBloodThe Lancet Oncology

In The Last Decade

A. V. Shubina

4 papers receiving 644 citations

Hit Papers

Subcutaneous versus intravenous administration of bortezo...20112026201620212011200400600

Peers

A. V. Shubina
Comparison fields: 5 of 53
  • Hematology 526
  • Molecular Biology 442
  • Oncology 352
  • Genetics 106
  • Pathology and Forensic Medicine 62
Replace Maria Grishunina with:
Maria Grishunina Russia
Grigoriy Rekhtman Ukraine
PR Greipp United States
Norbert Grząśko Poland
David Siegel United States
Kathleen Kelly United States
Mary McKenney United States
Alessandra Bertola Italy
MA Gertz United States
Maria Gavino United States
A. V. Shubina relative to Maria Grishunina Russia Maria Grishunina's profile →
Citations per field
00.5×1.5×
Maria Grishunina · 1×
Citations per year

Countries citing papers authored by A. V. Shubina

Since Specialization
Citations

This map shows the geographic impact of A. V. Shubina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Shubina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Shubina more than expected).

Fields of papers citing papers by A. V. Shubina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Shubina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Shubina. The network helps show where A. V. Shubina may publish in the future.

Co-authorship network of co-authors of A. V. Shubina

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Shubina. A scholar is included among the top collaborators of A. V. Shubina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Shubina. A. V. Shubina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 2
2
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority studybreakdown →
661
3 5
4 1

About A. V. Shubina

A. V. Shubina is a scholar working on Hematology, Biochemistry and Infectious Diseases, having authored 4 papers that have together received 669 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hematology (526 citations), Oncology (352 citations) and Genetics (106 citations). A. V. Shubina has collaborated with scholars based in Russia, Ukraine and United Kingdom. Frequent co-authors include Dixie‐Lee Esseltine, Helgi van de Velde, Jean‐Luc Harousseau, Zvenyslava Masliak, Martin Kropff, Sebastian Grosicki, Xavier Leleu, Huaibao Feng, James Cavet and Suzette Girgis. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026